Personalized T-cell therapy eliminates detectable metastatic kidney tumor in adolescent after multiple relapses
Researchers and physicians at the Hopp Children's Cancer Center Heidelberg (KiTZ) and other leading cancer centers report an exceptional treatment outcome in an adolescent with an advanced, treatment-resistant kidney tumor. Using a novel, personalized T-cell therapy, they succeeded in completely rev
<p>Researchers and physicians at the Hopp Children's Cancer Center Heidelberg (KiTZ) and other leading cancer centers report an exceptional treatment outcome in an adolescent with an advanced, treatment-resistant kidney tumor. Using a novel, personalized T-cell therapy, they succeeded in completely rev</p>